Table III.
Changes in inflammatory factors in both groups at 1 week and 1 month after treatment (mean ± SD).
| Group | Treatment | hs-CRP (ml/l) | IL-6 (ng/l) | TNF-α (ng/l) |
|---|---|---|---|---|
| Observation group | 1 week after treatment | 12.3±0.5 | 0.59±0.06 | 136.8±11.1 |
| 1 month after treatment | 8.5±0.3a,b | 0.43±0.04a,b | 83.2±7.6a,b | |
| Control group | 1 week after treatment | 14.6±0.6 | 0.68±0.06 | 146.5±11.3 |
| 1 month after treatment | 11.6±0.4a | 0.51±0.05a | 108.9±8.3a | |
| t1 | 41.217 | 14.033 | 25.199 | |
| p1 | <0.001 | <0.001 | <0.001 | |
| t2 | 26.312 | 13.766 | 16.961 | |
| p2 | <0.001 | <0.001 | <0.001 | |
| t3 | 39.212 | 7.902 | 14.443 | |
| p3 | <0.001 | <0.001 | <0.001 |
a
P<0.05 vs. observation group and control group at 1 week after treatment
b
P<0.05 vs. control group at 1 week after treatment. t1, the results of comparison in observation group between 1 month after treatment and 1 week after treatment. t2, the results of comparison in observation group between 1 month after treatment and 1 week after treatment. t3, the results of comparison between observation group and control group at 1 month after treatment.